SEC Form 4 · accession 0001209191-18-039348
HERON THERAPEUTICS, INC. /DE/ · HRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Barry D Quart
Officer — Chief Executive Officer · Director
Period of report
Jun 21, 2018
Accepted (ET)
Jun 22, 2018 · 9:35 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000818033
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 30, 2018 | J | 1,607 | $13.2175 | A | 69,600 | D | |
| Common Stock | Jun 21, 2018 | M | 50,000 | $9.05 | A | 119,600 | D | |
| Common Stock | Jun 21, 2018 | S | 50,000 | $39.05 | D | 69,600 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F3 | $9.05 | Jun 21, 2018 | M | 50,000 | D | — | Dec 12, 2024 | Common Stock | 50,000 | 250,000 | D |
Explanation of responses
- F1Represents shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan on April 30, 2018.
- F2The stock option exercise and sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan executed in December 2017.
- F3The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the date of grant (12/12/2014).